4//SEC Filing
SCHMIDT ERIC THOMAS 4
Accession 0001214659-21-005926
CIK 0001737287other
Filed
May 25, 8:00 PM ET
Accepted
May 26, 8:00 AM ET
Size
7.8 KB
Accession
0001214659-21-005926
Insider Transaction Report
Form 4
SCHMIDT ERIC THOMAS
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-05-24−14,897→ 94,703 totalExercise: $18.22Exp: 2030-03-18→ Common Stock (14,897 underlying) - Exercise/Conversion
Common Stock
2021-05-24$18.22/sh+14,897$271,423→ 110,994 total
Holdings
- 1,152,595(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]The securities are held in the name of the Eric Schmidt 2017 Family Irrevocable Trust.
- [F2]25% of the shares subject to the stock option shall vest on the first anniversary of the grant date, and the remaining shares shall vest in 36 equal monthly installments thereafter.
Documents
Issuer
Allogene Therapeutics, Inc.
CIK 0001737287
Entity typeother
Related Parties
1- filerCIK 0001754403
Filing Metadata
- Form type
- 4
- Filed
- May 25, 8:00 PM ET
- Accepted
- May 26, 8:00 AM ET
- Size
- 7.8 KB